Diabetes News

 

Beyond Type 1 Launches Web Platform in Arabic 


Diabetes information, stories, and news are now available in Arabic at ar.beyondtype1.org.MORE

COVID-19 Vaccines For Kids Ages 5 to 11 With Diabetes: What to Know


COVID-19 vaccines are now available for kids age 5+! Learn about safety and managing side effects for kids with Type 1 diabetes.MORE
vertex pharmaceuticals stem cell therapy for type 1 diabetes

Stem-Cell Therapy for Type 1 Diabetes Reduced Patient’s Insulin Needs by 91%


The early results of a clinical trial using stem-cell therapy to treat Type 1 diabetes reduced the patient’s insulin needs by 91%.MORE

Lilly Announces Lower List price for Insulin Lispro


The company will lower the list price of the generic version of Humalog in the U.S. by an additional 40 percent starting January 1, 2022.MORE

Lilly Issues Voluntary Nationwide Recall of One Lot of Glucagon Emergency Kit


Lilly announced the voluntary recall of lot D239382D, Expiration April 2022 of Glucagon Emergency Kits.MORE
Latinx Diabetes Initiative

The Latinx Diabetes Initiative Provides Culturally Tailored Care To Latinx Patients With Diabetes


Andreina Millan Ferro is centering culturally sensitive diabetes care for Latinx patients with diabetes at the Latinx Diabetes Initiative.MORE
Yarishdy Mora

Yarishdy Mora Is Empowering Youth Through Diabetes Education In Mexico


Yarishdy Mora is the director of the Youth Health Program for Project HOPE in Mexico. She creates platforms that help youth learn about diabetes. MORE
Screened for Type 2 Diabetes

Overweight Adults to Now Be Screened for Type 2 Diabetes At 35


The U.S. Preventive Services Task Force now recommends overweight and obese adults to get screened for Type 2 diabetes at the age of 35.MORE
pandemic homelessness

Pandemic Homelessness Disproportionately Impacts People With Diabetes


An American Diabetes Association report found that pandemic homelessness hit people with diabetes 48 times harder.MORE
Freestyle Libre 2

Abbott’s FreeStyle Libre 2 App Receives FDA Clearance


On August 2, 2021, the FDA approved the FreeStyle Libre 2 app for adults and children with diabetes, allowing user to access glucose readings directly from their iPhone.MORE
Senza

FDA Approves Senza®, Nevro’s High Frequency Spinal Cord Stimulation Therapy For PDN


The Senza System has been approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy.MORE
Semglee

Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin


Semglee becomes the first interchangeable biosimilar insulin product for the treatment of Type 1 and Type 2 diabetes.MORE
Culturally Sensitive LGBTQ+ Diabetes Health Care

Providing Culturally Sensitive LGBTQ+ Diabetes Health Care


Culturally sensitive LGBTQ+ diabetes health care can decrease stigma and advance diabetes care access for the LGBTQ community. MORE
Black Mother With Type 1 Diabetes

High Risk Pregnancy – Mitigating Risks for Type 1 Diabetes + Black Maternal Health Outcomes


Ariel Lawrence, a diabetes advocate and Black mother with Type 1 diabetes, shares how she navigated her pregnancy. MORE
disparities in pediatric diabetes

Addressing Disparities in Pediatric Diabetes Treatment In Philadelphia


Terri Lipman shares how incorporating community health workers can tackle disparities in pediatric diabetes treatment. MORE
teplizumab

FDA Issues CRL for Teplizumab, Investigational Candidate to Delay the Onset of T1D


The FDA issues a complete response letter to Provention Bio as part of an update for Teplizumab to delay the onset of Type 1 diabetes.MORE

Combating Diabetes Disparities Among The Hispanic Population


At ADA 2021, David Marrero discusses how culturally tailored care can combat diabetes disparities among the Hispanic population.MORE
walmart

Walmart Launches Lower-Cost Analog Insulin: ReliOn NovoLog


ReliOn NovoLog will be available at Walmart and Sam's Club pharmacies for $72.88 per vial and $85.88 per box of five FlexPens.MORE
depression among african american

Preliminary Findings On Depression Among African American and Latino Parents of Children With T1D


Samantha Carreon shares preliminary data on the TEAM study which found higher rates of depression among African American and Latino parents.MORE
JP Qualters

Making Broadway More Accessible With JP Qualters


JP Qualters shares his experience on Broadway as a person living with Type 1 diabetes and his aspirations for the theater industry.MORE
Zegalogue®

Zegalogue® Is Now Commercially Available In The United States


Zegalogue®, also known as dasiglucagon, is now commercially available in the U.S. for the treatment of severe hypoglycemia.MORE
continuous glucose monitor coverage

Medicare Loosens Restrictions on Continuous Glucose Monitor Coverage


Medicare revised its local coverage determination policy to remove requirements for continuous glucose monitor coverage.MORE
ACA intact

Supreme Court Votes To Keep The ACA Intact


The Affordable Care Act (ACA) provides health care to millions of Americans. The Supreme Court voted 7-2 to keep the ACA intact.MORE
vaccine access

COVID-19 Vaccines And Diabetes: Vaccine Access Issues For People Of Color


Communities of color with diabetes face a myriad of barriers when it comes to vaccine access. Experts share how the U.S. can achieve vaccine equity.MORE
diabetes program accessibility

Michelle L. Litchman Focuses On Diabetes Program Accessibility For People Who Are Deaf


Michelle L. Litchman was named a Betty Irene Moore Nurse Fellow. She will focus on diabetes program accessibility for people who are deaf.MORE

Test Strip Subscription Guide


We compiled a rundown of popular companies that offer test strip subscription services and researched each of them to give you some important info.MORE
omnipod 5

Omnipod 5 Pivotal Trial Data Published


Data from the pivotal trial shows that the Omnipod 5 improves time-in-range, and reduces HbA1c and mean glucose levels. MORE
ATTD 2021

Breaking News From ATTD 2021


This year, ATTD 2021 will be held virtually where developers and clinicians will present their new diabetes technology and research.MORE
mental health

Survey Finds the Pandemic Increased Mental Health Concerns Among People With Diabetes


Cecelia Health conducted a survey that revealed increased mental health concerns among people with diabetes during the COVID-19 pandemic. MORE
teplizumab

FDA Advisory Committee Votes 10-7 To Recommend Approval of Teplizumab For Delay Of Type 1 Diabetes


Teplizumab is an investigational candidate proven to delay the onset of Type 1 diabetes. The FDA advisory committee reviews Provention Bio Inc.'s application.MORE
bullying

Combating Bullying: How One Person With Diabetes Fought To Test Her Blood Sugar In The Workplace


Sheri Byrne shares her experience on how she fought workplace bullying due to diabetes and advocated for herself.MORE
Bigfoot Unity

Bigfoot Unity™ Diabetes Management System Receives The Green Light From The FDA


Bigfoot Unity™, a one-of-a-kind diabetes management system with smart pen caps received FDA approval on May 10, 2021 and will reach select diabetes clinics this spring. MORE

Asian Isn’t A Monolith: Why More Specific Data Matters in Diabetes Research


Data on how diabetes impacts specific ethnic groups could help us better support people within Asian American Pacific Islander communities.MORE
ramadan

This Is How People With Type 1 Diabetes Are Observing Ramadan


People with diabetes face their own set of challenges when observing Ramadan. Two people with diabetes share their experiences. MORE

The PROTECT Study 


The PROTECT Study aims to understand how the investigational medicine, teplizumab, works in children and young adults who have recently been diagnosed with T1D, as well as assessing if there are any s...MORE
aapi diabetes research

Chris Hahm’s Uphill Battle: The Severe Underfunding of AAPI Diabetes Research


H. Chris Hahm shares her challenges of conducting diabetes research focused on the AAPI community, research that is severely underfunded.MORE

CDC and FDA Call for Pause on Johnson & Johnson Vaccine


After six cases of rare blood clots, the CDC and FDA has advised healthcare professionals to pause on distributing the Johnson and Johnson vaccine.MORE

FDA Approves New Glucagon Option from Zealand Pharma


Available in June 2021, the FDA approved Zealand Pharma’s Zeagalogue, a new form of glucagon for people with insulin-dependent diabetes.MORE
ADA Collab

Two Pillars in the Diabetes Community Unite to Serve Millions Living with Diabetes


The partnership will feature combined resources, strategies, and tactics to better serve people living with type 1 diabetes, type 2 diabetes, and prediabetes.MORE

JDRF Announces New Center of Excellence to Advance T1D Research


On February 23, 2021, JDRF announced the launch of the JDRF Center of Excellence in collaboration with the Harvard Stem Cell Institute in New England.MORE

Get the Facts on Insulin Pricing + The Presidential Transition


A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin. MORE

New Year, New Administration: What’s Coming For US Healthcare Policy


With a new governmental administration, it is likely we will see notable and impactful movement in healthcare policy. What can we expect? MORE

Congress Renews Funding for Special Diabetes Program


On Dec 22, 2020, Congress renewed the Special Diabetes Program, providing $150 million annually in Type 1 diabetes research funding until 2023MORE

JDRF Launches Program to Advance Universal Screening for Type 1 Diabetes


T1Detect is a new screening initiative designed to make early detection of Type 1 diabetes easier and more accessible to a broad population. MORE

Diabetes + COVID Vaccines: What You Need to Know


If you have diabetes, here’s everything you need to know about the COVID-19 vaccines.MORE

Amazon Launches Online Pharmacy


Amazon Pharmacy, launched on November 17, delivers medications and prescription refills - such as insulin - with Prime membership 2-day shipping.MORE

Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch


Semglee (insulin glargine), from Mylan and Biocon, is now available by prescription in the United States in vial and pre-filled pen presentations.MORE

With SAG-AFTRA Healthcare Changes, Can T1Ds Stay in the Arts?


With recently announced SAG-AFTRA healthcare changes, do the majority of people with T1D realistically have the option to choose a profession in the arts? MORE

JDRF Announces Updated Strategy, Renewed Focus in Light of COVID-19


Amidst COVID-19, JDRF prioritizing work in their portfolio that they see as having the highest likelihood for cures and life changing advances for diabetes.MORE

Study Links COVID-19 to Increased Rates of DKA at Diagnosis in Children


In a German study from March to May 2020, nearly half of minors had DKA at Type 1 diabetes diagnosis - double previous years - amidst COVID-19.MORE

United Healthcare to Begin Covering Tandem Insulin Pumps


On July 1, 2020, United Healthcare (UHC) announced they will begin covering the Tandem t:slim X2 insulin pump, a departure from UHC’s four-year policy to only provide health insurance coverage for M...MORE

Preventing and Delaying Type 1 Diabetes: Updates From the Teplizumab Trial


Half of those treated with teplizumab remain diabetes-free, compared to 22% of those taking placebo, and the delay in diabetes onset was close to 3 years.MORE

Disparities in Diabetes and Diabetes Care—What Can We Do About It?


At this ADA 2020 session, systemic racism and implicit bias were clear contributors to poor health and healthcare outcomes for Black and Latinx communities.MORE

T1D Exchange + Beyond Type 1 Marathon Study Presented at ADA 2020


The Beyond Type Run team has taken on 26.2 miles to not only raise awareness and funds for T1D, but to provide crucial data for a study pertaining to management of Type 1 before, during, and after a m...MORE

One Drop Announces New Overnight Hypo Predictions and Long-Term Health Forecasts at ADA 2020


One Drop unveiled new AI-powered predictions for blood glucose, A1C, blood pressure, and weight up to six months in advanceMORE

FreeStyle Libre 2 Approved for Use in U.S.


Those living with Type 1 diabetes in the U.S. now have the opportunity to manage their disease utilizing the perks of Abbott’s Freestyle Libre 2. MORE

Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020


Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.MORE

New Research Resource from Beyond Type 1 Aims to Bridge the Gap Between Science and Community


A new collection of resources shared today by Beyond Type 1 breaks down the most impactful current Type 1 diabetes research into quick and easy to understand information. MORE

Medicare Part D Senior Savings Model Caps Insulin Costs at $35 per Month


The Senior Savings Model caps out of pocket insulin costs at $35 per month for seniors enrolled in eligible plans.MORE

England’s NHS Releases Study on Risk of COVID-19 for People with Diabetes


This week, the National Health Service (NHS) in England released the first study of its kind, breaking down COVID-19 mortality risk by type of diabetes.MORE

Armed For Diabetes Created to Help Veterans With Resources For Better Diabetes Management


Armed for Diabetes highlights continuous glucose monitoring prescribing guidelines for veterans.MORE

Roche Offers Free Access to mySugr Pro During COVID-19


With the rise of telemedicine during COVID-19, free access to mySugr Pro will help people stay connected to their healthcare team. MORE

Minnesota Passes the Alec Smith Insulin Affordability Act


The Alec Smith Insulin Affordability Act was signed into law in Minnesota, providing MN residents options for emergency and ongoing insulin access for those who qualify.MORE

Novo Offers Free 90-Day Insulin Supply to People Recently Uninsured Due to COVID-19


Novo Nordisk announces program offering a free 90-day supply of Novo Nordisk insulin for those who have recently lost their health insurance coverage due to a change in job status because of COVID-19....MORE

Beyond Type 1 Asks Congress To Support Expanded Paid Leave For Chronic Conditions During COVID-19


Beyond Type 1 joined 156 other organizations in urging Congress to expand paid leave for those with chronic illness, who are at higher risk for complications from COVID-19.MORE

FreeStyle Libre Approved by FDA for Hospitalized Patients During COVID-19 Pandemic


Abbott's FreeStyle Libre 14 day system will allow doctors to remotely monitor their patient's glucose levels. MORE

New Program Offers $35 Monthly Copays for Lilly Insulins


Eli Lilly announced a new program that allows people in the US to fill their monthly prescription of Lilly insulin for $35 per month with a copay card.MORE

Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19


On March 26, Senseonics suspended all commercial sales of the Eversense continuous glucose monitor (CGM) in the United States.MORE

New Insulin Approval Pathway Could Increase Competition


The new regulatory pathway “is expected to increase patient access, adding more choices and potentially reducing costs of these vital therapies.”MORE

The Power in Numbers: Change.org’s Affordable Insulin For All Movement


As insulin prices continue to increase in the United States, Change.org is equipping those affected with the tools to speak out.MORE

New Medicare Plan Will Cap Insulin Copays at $35


On March 11, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin. MORE

The FAA continues to ground commercial pilots with insulin-dependent diabetes


Pilots with diabetes remain in the dark following the Federal Aviation Administration's updated medical certification guidelines.MORE

Omnipod Closed Loop Technology to be Compatible with Both Abbott and Dexcom CGMs


Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. MORE

Beyond Type 1 Launches in Five New Languages to Better Serve the Global Diabetes Community


Beyond Type 1 announced today the launch of websites in Dutch, French, German, Italian, and Swedish. The multi-language expansion is made possible with support from partners Dexcom and Insulet.MORE

FDA Issues Class I Recall of Certain Medtronic Insulin Pumps


The FDA announced Wednesday that it has issued a Class 1 recall of Medtronic MiniMed 600 Series insulin pumps, after reports of 2,175 injuries and 1 death.MORE

New Evidence Shows Vital Importance of Screening For T1D in Children


By screening for Type 1 diabetes in children, Bavaria was able to decrease rates of diabetic ketoacidosis at diagnosis.MORE

Omnipod Dash System Launches in First European Countries


On December 18, Insulet announced that the Omnipod DASH™ Insulin Management System is now officially available in the UK and the Netherlands. MORE

Join the Fit with Diabetes Challenge


Beyond Type 1 met up with Christel Oerum from Diabetes Strong for a chat about fitness and her next Fit With Diabetes Challenge which is kicking off on January 3.MORE

Tandem’s Control-IQ Hybrid Closed Loop Approved by the FDA


The FDA announced the approval of the Control-IQ Hybrid Closed Loop System from Tandem Diabetes Care. The system sees the t:slim X2 insulin pump and Dexcom G6 continuous glucose monitor working togeth...MORE

Gvoke HypoPen Now Available


On September 10 the FDA approved the Gvoke HypoPen and Gvoke PFS, emergency glucagon rescue devices for the treatment of severe hypoglycemia.MORE

Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk


Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.MORE

JDRF Launches Center of Excellence to Accelerate Cure for Type 1 Diabetes


On September 4, JDRF announced the launch of its Northern California Center of Excellence, dedicated to focused efforts on research and breakthroughs to cure Type 1 diabetes.MORE

People With Diabetes Forgoing Basic Needs in Order to Survive According to New Studies


According to two studies presented at the American Association of Diabetes Educators 2019 Annual Conference, people with diabetes are forgoing basic needs in the face of rising healthcare costs and ta...MORE
baqsimi nasal glucagon

Nasal Glucagon Baqsimi Approved by the FDA


On Thursday, the Food and Drug Administration approved Eli Lilly and Company's Baqsimi, a non-injectable, nasal glucagon and the first of its kind. MORE

Senate Bill Aims to Cut Price of Insulin by 75%


The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.MORE

New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care


The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.MORE

New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.


The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.MORE

JDRF Advocates Urge Congress to Renew Funding for T1D Research


On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.MORE

New Bipartisan ‘Emergency Access’ Bill Introduced to Lower Insulin Costs


Democratic Senator Tina Smith announced Thursday the rollout of a bipartisan bill to bring down insulin prices. The legislation features the set-up of an emergency insulin assistance program, which wo...MORE

T1D Exchange and Tidepool Partner with Beyond Type 1 to Study Athletes with Type 1 Diabetes 


Beyond Type 1 announces collaborative research study produced with T1DExchange + Tidepool, focusing on glycemic variability and exercise. MORE

Nonprofits Announce Groundbreaking Research Initiative


The Parker Institute, JDRF and The Leona M. and Harry B. Helmsley Charitable Trust announced a research initiative to study immunotherapy-induced diabetes. MORE

Colorado Becomes First State to Pass Bill Capping Insulin Costs


On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.MORE

FDA Approves New Treatment for Diabetic Retinopathy


Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.MORE

Express Scripts Won’t Cover Lilly’s Generic Insulin


The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication. MORE

Omnipod DASH System Now Available in the U.S.


The Omnipod DASH™ Insulin Management System is now officially available in the United States following a limited marketing release.MORE

European Commission Approves Zynquista, First Dual SGLT Inhibitor for T1D


Zynquista is the first dual SGLT1 and SGLT2 inhibitor approved for use in Type 1 diabetes, and the second oral medication approved for use in Type 1 diabetes. MORE

Woman’s Insulin Confiscated By Airport Security


A woman boarding a flight in the UK had her insulin taken from her by airport security and subsequently boarded her flight without it.MORE

DIY Loop Now Compatible with Omnipod


Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.MORE

Previously Healthy from Beyond Type 1 Named Webby People’s Voice Award Winner


Hailed as the “Internet’s highest honor” and “the Oscars of the Internet” The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS) honoring excellence...MORE

Insulin Manufacturers and PBMs Testify Before Congress


The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.MORE